X-37
X-37 is a pharmaceutical discovery and development company leveraging AI-driven approaches to target difficult-to-drug proteins across a broad chemical space. The company focuses on high therapeutic value targets implicated in autoimmune diseases, cancer, and anticoagulation. X-37 collaborates with AI technology partners to identify potent and selective small molecules, accelerating drug discovery. Their management team has extensive experience in drug development and regulatory approval, positioning the company to innovate in challenging drug discovery areas with potential for safe and effective therapies.
X-37
X-37 is a pharmaceutical discovery and development company leveraging AI-driven approaches to target difficult-to-drug proteins across a broad chemical space. The company focuses on high therapeutic value targets implicated in autoimmune diseases, cancer, and anticoagulation. X-37 collaborates with AI technology partners to identify potent and selective small molecules, accelerating drug discovery. Their management team has extensive experience in drug development and regulatory approval, positioning the company to innovate in challenging drug discovery areas with potential for safe and effective therapies.